FRENKEL JACOB A
SEC insider (Form 3/4/5 filer). CIK 0001237418. Director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 24, 2026. Located in NEW YORK, NY.
Companies FRENKEL JACOB A has filed insider reports for
- BRAINSTORM CELL THERAPEUTICS INC. (BCLI): Director
FRENKEL JACOB A
CIK: 0001237418
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Director